RCEL - Avita Medical Limited

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in AUD. All numbers in thousands
Breakdown
ttm
6/29/2019
6/29/2018
6/29/2017
6/29/2016
Total Revenue
-
7,705
1,199
1,181
1,002
Cost of Revenue
-
1,698
512
506
402
Gross Profit
-
6,008
687
675
600
Operating Expenses
Research Development
-
14,362
12,606
4,692
3,458
Selling General and Administrative
-
35,664
16,132
15,481
10,931
Total Operating Expenses
-
41,767
18,634
20,173
14,389
Operating Income or Loss
-
-35,759
-17,947
-19,498
-13,788
Interest Expense
-
38
27
13
0
Total Other Income/Expenses Net
-
457
69
6,828
2,434
Income Before Tax
-
-35,340
-17,905
-12,559
-11,244
Income Tax Expense
-
-180
-1,386
-1,048
-972
Income from Continuing Operations
-
-35,160
-16,519
-11,511
-10,272
Net Income
-
-35,160
-16,519
-11,511
-7,778
Net Income available to common shareholders
-
-35,160
-16,519
-11,511
-7,778
Reported EPS
Basic
-
-
-0.35
-0.31
-0.31
Diluted
-
-
-0.35
-0.31
-0.31
Weighted average shares outstanding
Basic
-
-
46,830
37,479
28,007
Diluted
-
-
46,830
37,479
28,007
EBITDA
-
-35,302
-17,735
-12,547
-11,244